Actively Recruiting
High Resolution Diffusion Weighted Imaging in Prostate
Led by The First Affiliated Hospital with Nanjing Medical University · Updated on 2024-10-15
500
Participants Needed
2
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
hrDWI might be an alternative to cDWI for the prostate imaging. 1. increase the signal-to-noise ratio and contrast-to-noise ratio, yielding high-fidelity images with less noise in general 2. improve the diagnostic accuracy of PCa in particular than conventional DWI
CONDITIONS
Official Title
High Resolution Diffusion Weighted Imaging in Prostate
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who underwent standard MR scanning including T2WI, cDWI, hrDWI and respective calculated apparent diffusion coefficient (ADC) maps
- Complete clinical information
You will not qualify if you...
- Men using 5-alpha-reductase inhibitors at time of examination or within the previous six months
- History of prostatic biopsy, prostatic surgery, or treatment for prostate cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China
Actively Recruiting
2
Yu-Dong Zhang
Nanjing, China, 210029
Actively Recruiting
Research Team
Y
Yu-Dong Zhang
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here